Share Name Share Symbol Market Type Share ISIN Share Description
Life Science De LSE:LIFE London Ordinary Share VGG7255F1062 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2.375p 0.00p 0.00p - - - 0 06:31:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining 0.0 -10.8 -27.1 - 0.89

Life Science De Share Discussion Threads

Showing 401 to 421 of 425 messages
Chat Pages: 17  16  15  14  13  12  11  10  9  8  7  6  Older
DateSubjectAuthorDiscuss
13/7/2017
16:55
PulseFlowTech‏ @PulseFlowTech Tom Nicolette from the Nicolette Consulting Group has joined our company to help with forthcoming fundraising
adred
10/4/2017
11:02
You have to ask yourself, was it ever LIFE's intention to act as a genuine, unconstrained, investment seeking shell? Given that in their founding EGM 'mission statement' (see above post 263) they demonstrably and dishonourably mislead their investors by pledging an EGM to return residual cash in the event of delisting, which they have subsequently refused to hold - the reasonable question then arises - was the rest of that statement also disingenuous at best? I.e. did LIFE ever seriously intend to consider anything apart from Mellon's deeply unloved baby, the Diabetic Boot Co, as an 'investment'? Now you have the blackly farcical situation where LIFE's twin assets, ie the cash and the AIM listing, have been squandered in the single minded, yet so far comically unsuccessful, pursuit of a non exec director (Jim Mellon) related party deal - with that same unloved baby the DBC, and, (especially preposterous this bit), at a price level apparently much higher than other Mellon associated companies had already declined to further invest in said DBC at. It seems this unpopularity meant the DBC could not even be listed on the AIM before the deadline expired, and may well never be, making LIFE's enthusiastic, unrequited courtship, where others sensibly feared to tread - beyond ludicrous. And that low interest, unsecured loan, that LIFE has chosen to extend, rather than refund its shareholders as promised - oh dear. When Mellon himself was obliged to step in with a further 2 million loan to re-bailout said DBC a few months later, he sensibly made sure it was fully secured. In whose interests has all this happened? I find it very hard to believe personally that it has been in any way, shape or form in LIFE the company's interests, which in law were supposed to be the Directors' prime concern, but perhaps that's just me :)
banshee
07/4/2017
10:10
What kind of retard can't make a shell with £1.5m work?
ap1982
22/3/2017
20:31
Half forgotten about this one, just had a look at twitter & the LSE BB where an uncertain consensus seems to be that today was the last day for news re an EGM to avoid delisting in 2 weeks. I don't know enough about the protocol personally to tell if this is true, but if it is the whole thing now looks rather sordid, even by the notoriously low standards of related party transactions (or non transactions in this case!). Any remaining shareholders here have my sympathy. Should the LSE etc be correct, the directors here look pretty awful and don't appear to give a toss about anyone but themselves. Call me a cynic, but I suspect the sudden burst of twitter activity is just there to cover up any tweets from disaffected investors.
banshee
15/3/2017
23:15
Still no news, anyone know when we are expected some news? Pulse Flow (DBC) twitter accounts has become alive this week could we see action soon?
adred
06/10/2016
20:12
You're in danger of turning into a serial shaftee :( But LIFE shareholders have the special privilege of paying handsomely to be shafted. The DBC is total dross imo, from an investment point of view, worth a lot closer to £1.50 than £15 million. Mellon appears to have curtailed his own planned investment in it via Regency, presumably on the back of poor performance, and his protege in the FFWD project we are told, won't invest either (even with other peoples money), but LIFE shareholders are being marched forward merrily to fill the gap at a rather higher and more demanding valuation than others, who are better informed, have already turned down - or so it would seem. It would also seems that LIFE shareholders residual cash investment will only give them a stake pretty much on a par level with the potential new (essential but perhaps also certifiable?) investors per pound invested, whilst the LIFE AIM shell itself, with its substantial accumulated tax losses, is to be a free gift? This might seem to some to be a ludicrously bad deal. I get the distinct feeling that Mitch Anand is unlikely to be nominated for businessman of the year anytime soon. Oh, and thanks for the emergency, totally unsecured, financing - on very generous terms indeed, try getting a no strings, where-do-i-sign-to-keep-your-lights-on-who-cares-if-you-go-bust, bail out deal like that from a commercial lender. All IMO,DYOR etc.
banshee
06/10/2016
20:04
From the telegraph 2014 Jim Mellon, the biotech investor, is putting his best foot forward with his latest stock market foray. The Diabetic Boot Company, as the medical shoe-maker is known, is currently exploring all forms of financing after an initial £1m investment round, with the preferred outcome a flotation on Aim, pencilled in for late August. No banks have been appointed as advisers yet, but Mellon, who owns a 40pc stake in the company through his Burnbrae vehicle, estimates its IPO valuation at around £15m. ------------------------------------------------------------------ Have to wait and see what happens. Shafted with Plethora/Regency Pacific via Mellon Let's seen if we get shafted again........ Only got a grand as a punt mind.
rusty9717
06/10/2016
07:25
Massive news may come back much higher
nw99
30/9/2016
07:59
IOF about to take off, debt restructuring agreed
liquidgold1
29/9/2016
08:50
So a possible investment for LIFE? why mentioned it today if no investment is linned up, could a very exciting week
fishybits
29/9/2016
08:28
What share price target are we looking at? Im tempted
the patient investor
29/9/2016
08:25
Yes very easy it is reversing into a biotech company cash shell
nw99
29/9/2016
08:23
Can sb enlighten me re why this share price climb? Many tx
the patient investor
29/9/2016
07:11
Picked up some cheap ones
nw99
29/9/2016
06:04
Great rns suspension 6/10 acquisition coming
nw99
01/9/2016
13:27
Jim Mellon interview around the 20 minute mark. Https://audioboom.com/boos/4999566-574-tony-gilby-of-tlou-energy-and-jim-mellon
lr2
31/8/2016
21:55
Let's see what Jim Mellon has to say on Voxmarkets Podcast tomorrow #life
john_l
31/8/2016
12:48
Yes very!! This has been ignored so ??? What's going on?
moormoney
31/8/2016
12:46
Mmmmmmmmmmmm Interesting
rusty9717
18/7/2016
12:11
Buyers coming in again today....nice!!
moormoney
30/6/2016
12:55
Results out, cash in the bank and they are working on potential life science deals. I think the share price rise indicates news soon IMO.
moormoney
Chat Pages: 17  16  15  14  13  12  11  10  9  8  7  6  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20171119 18:11:37